1
|
Bjermo H, Patterson E, Petrelius Sipinen J, Lignell S, Stenberg K, Larsson E, Lindroos AK, Ottoson J, Warensjö Lemming E, Moraeus L. Design, Methods, and Participation in Riksmaten Young Children-A Swedish National Dietary Survey. Curr Dev Nutr 2024; 8:102150. [PMID: 38774498 PMCID: PMC11107201 DOI: 10.1016/j.cdnut.2024.102150] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/07/2023] [Revised: 03/21/2024] [Accepted: 03/26/2024] [Indexed: 05/24/2024] Open
Abstract
Background National dietary surveys provide essential data for risk benefit assessments of foods and nutrients, for management and policy development. Physical activity measurement and biomonitoring can provide important complementary data but are less commonly included. Objectives This study aimed to describe the study design and methods of the cross-sectional Swedish national dietary survey Riksmaten Young Children (Riksmaten småbarn), of children aged 9 mo, 18 mo, and 4 y. Participation/dropout rates for the 2 older age groups are also presented. The impact of different recruitment strategies is discussed. Methods Children (N = 16,655) were randomly selected from the population register; invitations to guardians were sent by post and where possible, followed up by telephone. Food intake was assessed by a 2-d food diary and/or questionnaire. Height and weight were reported after measurement. Physical activity (accelerometery, 7 d) and stool, blood, and urine samples were assessed in subgroups. Results Food consumption data were collected in 1828 children (11% of the invited; 18 mo: n = 1078, and 4 y: n = 750). Of participants also in subgroups, 71% provided physical activity data (n = 1307), 60% stool samples (n = 630), and 51% blood and/or urine samples (n = 593). The study population represented all geographic regions and types of municipalities in Sweden, but participating households had both higher education level and higher income than the target population. Only minor differences were seen in participation rates between recruitment via post and telephone compared with those through post only (12% compared with 10%). Repeated contact attempts were needed for the majority of participants (65%). Despite the low-participation rate, 99% of the participants completed the study once started. Conclusions Although it was a challenge to recruit participants, Riksmaten Young Children provides a substantial amount of information at national level, representative in terms of sex, geography, and family structure. The underrepresentation of households with lower socioeconomic position must be considered when generalizing results.
Collapse
Affiliation(s)
- Helena Bjermo
- Department of Risk Benefit Assessment, Swedish Food Agency, Uppsala, Sweden
| | - Emma Patterson
- Department of Risk Benefit Assessment, Swedish Food Agency, Uppsala, Sweden
- Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden
| | | | - Sanna Lignell
- Department of Risk Benefit Assessment, Swedish Food Agency, Uppsala, Sweden
| | - Karin Stenberg
- Department of Risk Benefit Assessment, Swedish Food Agency, Uppsala, Sweden
| | - Elin Larsson
- Department of Risk Benefit Assessment, Swedish Food Agency, Uppsala, Sweden
| | - Anna Karin Lindroos
- Department of Risk Benefit Assessment, Swedish Food Agency, Uppsala, Sweden
- Department of Internal Medicine and Clinical Nutrition, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
| | - Jakob Ottoson
- Department of Risk Benefit Assessment, Swedish Food Agency, Uppsala, Sweden
| | - Eva Warensjö Lemming
- Department of Food Studies, Nutrition and Dietetics, Uppsala University, Uppsala, Sweden
- Medical Epidemiology, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden
| | - Lotta Moraeus
- Department of Risk Benefit Assessment, Swedish Food Agency, Uppsala, Sweden
| |
Collapse
|
2
|
Ubong D, Stewart L, Sepai O, Knudsen LE, Berman T, Reynders H, Van Campenhout K, Katsonouri A, Van Nieuwenhuyse A, Ingelido AM, Castaño A, Pedraza-Díaz S, Eiríksdóttir ÁV, Thomsen C, Hartmann C, Gjorgjev D, De Felip E, Tolonen H, Santonen T, Klanova J, Norström K, Kononenko L, Silva MJ, Uhl M, Kolossa-Gehring M, Apel P, Jõemaa M, Jajcaj M, Estokova M, Luijten M, Lebret E, von Goetz N, Holcer NJ, Probst-Hensch N, Cavaleiro R, Barouki R, Tarroja E, Balčienė RM, Strumylaite L, Latvala S, Namorado S, Szigeti T, Ingi Halldorsson T, Olafsdottir K, Wasowicz W. Application of human biomonitoring data to support policy development, raise awareness and environmental public health protection among countries within the HBM4EU project. Int J Hyg Environ Health 2023; 251:114170. [PMID: 37207539 DOI: 10.1016/j.ijheh.2023.114170] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/17/2022] [Revised: 04/16/2023] [Accepted: 04/17/2023] [Indexed: 05/21/2023]
Abstract
Most countries have acknowledged the importance of assessing and quantifying their population's internal exposure from chemicals in air, water, soil, food and other consumer products due to the potential health and economic impact. Human biomonitoring (HBM) is a valuable tool which can be used to quantify such exposures and effects. Results from HBM studies can also contribute to improving public health by providing evidence of individuals' internal chemical exposure as well as data to understand the burden of disease and associated costs thereby stimulating the development and implementation of evidence-based policy. To have a holistic view on HBM data utilisation, a multi-case research approach was used to explore the use of HBM data to support national chemical regulations, protect public health and raise awareness among countries participating in the HBM4EU project. The Human Biomonitoring for Europe (HBM4EU) Initiative (https://www.hbm4eu.eu/) is a collaborative effort involving 30 countries, the European Environment Agency (EEA) and the European Commission (contracting authority) to harmonise procedures across Europe and advance research into the understanding of the health impacts of environmental chemical exposure. One of the aims of the project was to use HBM data to support evidence based chemical policy and make this information timely and directly available for policy makers and all partners. The main data source for this article was the narratives collected from 27 countries within the HBM4EU project. The countries (self-selection) were grouped into 3 categories in terms of HBM data usage either for public awareness, policy support or for the establishment HBM programme. Narratives were analysed/summarised using guidelines and templates that focused on ministries involved in or advocating for HBM; steps required to engage policy makers; barriers, drivers and opportunities in developing a HBM programme. The narratives reported the use of HBM data either for raising awareness or addressing environmental/public health issues and policy development. The ministries of Health and Environment were reported to be the most prominent entities advocating for HBM, the involvement of several authorities/institutions in the national hubs was also cited to create an avenue to interact, discuss and gain the attention of policy makers. Participating in European projects and the general population interest in HBM studies were seen as drivers and opportunities in developing HBM programmes. A key barrier that was cited by countries for establishing and sustaining national HBM programmes was funding which is mainly due to the high costs associated with the collection and chemical analysis of human samples. Although challenges and barriers still exist, most countries within Europe were already conversant with the benefits and opportunities of HBM. This article offers important insights into factors associated with the utilisation of HBM data for policy support and public awareness.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | - Dragan Gjorgjev
- Institute of Public Health, Republic of North Macedonia, Macedonia
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
3
|
Santonen T, Mahiout S, Alvito P, Apel P, Bessems J, Bil W, Borges T, Bose-O'Reilly S, Buekers J, Cañas Portilla AI, Calvo AC, de Alba González M, Domínguez-Morueco N, López ME, Falnoga I, Gerofke A, Caballero MDCG, Horvat M, Huuskonen P, Kadikis N, Kolossa-Gehring M, Lange R, Louro H, Martins C, Meslin M, Niemann L, Díaz SP, Plichta V, Porras SP, Rousselle C, Scholten B, Silva MJ, Šlejkovec Z, Tratnik JS, Joksić AŠ, Tarazona JV, Uhl M, Van Nieuwenhuyse A, Viegas S, Vinggaard AM, Woutersen M, Schoeters G. How to use human biomonitoring in chemical risk assessment: Methodological aspects, recommendations, and lessons learned from HBM4EU. Int J Hyg Environ Health 2023; 249:114139. [PMID: 36870229 DOI: 10.1016/j.ijheh.2023.114139] [Citation(s) in RCA: 6] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2022] [Revised: 02/13/2023] [Accepted: 02/14/2023] [Indexed: 03/06/2023]
Abstract
One of the aims of the European Human Biomonitoring Initiative, HBM4EU, was to provide examples of and good practices for the effective use of human biomonitoring (HBM) data in human health risk assessment (RA). The need for such information is pressing, as previous research has indicated that regulatory risk assessors generally lack knowledge and experience of the use of HBM data in RA. By recognising this gap in expertise, as well as the added value of incorporating HBM data into RA, this paper aims to support the integration of HBM into regulatory RA. Based on the work of the HBM4EU, we provide examples of different approaches to including HBM in RA and in estimations of the environmental burden of disease (EBoD), the benefits and pitfalls involved, information on the important methodological aspects to consider, and recommendations on how to overcome obstacles. The examples are derived from RAs or EBoD estimations made under the HBM4EU for the following HBM4EU priority substances: acrylamide, o-toluidine of the aniline family, aprotic solvents, arsenic, bisphenols, cadmium, diisocyanates, flame retardants, hexavalent chromium [Cr(VI)], lead, mercury, mixture of per-/poly-fluorinated compounds, mixture of pesticides, mixture of phthalates, mycotoxins, polycyclic aromatic hydrocarbons (PAHs), and the UV-filter benzophenone-3. Although the RA and EBoD work presented here is not intended to have direct regulatory implications, the results can be useful for raising awareness of possibly needed policy actions, as newly generated HBM data from HBM4EU on the current exposure of the EU population has been used in many RAs and EBoD estimations.
Collapse
Affiliation(s)
| | | | - Paula Alvito
- National Institute of Health Dr. Ricardo Jorge, 1649-016, Lisbon, Portugal; Centre for Environmental and Marine Studies (CESAM), University of Aveiro, 3810-193 Aveiro, Portugal
| | - Petra Apel
- German Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany
| | - Jos Bessems
- VITO-Flemish Institute for Technological Research, Mol, Belgium
| | - Wieneke Bil
- National Institute for Public Health and the Environment, Bilthoven, the Netherlands
| | - Teresa Borges
- General-Directorate of Health, Ministry of Health, 1049-005, Lisbon, Portugal
| | - Stephan Bose-O'Reilly
- Department of Public Health, Health Services Research and Health Technology Assessment, UMIT - Private University for Health Sciences, Medical Informations und Technology, Hall i.T., Austria
| | - Jurgen Buekers
- VITO-Flemish Institute for Technological Research, Mol, Belgium
| | | | - Argelia Castaño Calvo
- National Centre for Environmental Health, Instituto de Salud Carlos III, Madrid, Spain
| | | | | | - Marta Esteban López
- National Centre for Environmental Health, Instituto de Salud Carlos III, Madrid, Spain
| | | | - Antje Gerofke
- German Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany
| | | | | | | | | | | | - Rosa Lange
- German Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany
| | - Henriqueta Louro
- National Institute of Health Dr. Ricardo Jorge, 1649-016, Lisbon, Portugal; ToxOmics-Centre for Toxicogenomics and Human Health, NOVA Medical School, Universidade NOVA de Lisboa, Campo dos Mártires da Pátria, 130, 1169-056, Lisboa, Portugal
| | - Carla Martins
- NOVA National School of Public Health, Public Health Research Centre, NOVA University Lisbon, 1600-560, Lisbon, Portugal; Comprehensive Health Research Center (CHRC), NOVA University Lisbon, 1600-560, Lisbon, Portugal
| | - Matthieu Meslin
- French Agency for Food, Environmental and Occupational Health & Safety, Anses, 14 rue Pierre et Marie Curie, 94701, Maisons-Alfort, France
| | - Lars Niemann
- German Federal Institute for Risk Assessment, Berlin, Germany
| | - Susana Pedraza Díaz
- National Centre for Environmental Health, Instituto de Salud Carlos III, Madrid, Spain
| | - Veronika Plichta
- Austrian Agency for Health and Food Safety, Department Risk Assessment, Spargelfeldstraße 191, 1220, Vienna, Austria
| | | | - Christophe Rousselle
- French Agency for Food, Environmental and Occupational Health & Safety, Anses, 14 rue Pierre et Marie Curie, 94701, Maisons-Alfort, France
| | - Bernice Scholten
- Research Group Risk Analysis for Products in Development, The Netherlands Organisation for Applied Scientific research (TNO), Utrecht, the Netherlands
| | - Maria João Silva
- National Institute of Health Dr. Ricardo Jorge, 1649-016, Lisbon, Portugal; ToxOmics-Centre for Toxicogenomics and Human Health, NOVA Medical School, Universidade NOVA de Lisboa, Campo dos Mártires da Pátria, 130, 1169-056, Lisboa, Portugal
| | | | | | | | - Jose V Tarazona
- National Centre for Environmental Health, Instituto de Salud Carlos III, Madrid, Spain; European Food Safety Authority (EFSA), Parma, Italy
| | - Maria Uhl
- Environment Agency Austria, Spittelauer Lände 5, 1090, Vienna, Austria
| | | | - Susana Viegas
- NOVA National School of Public Health, Public Health Research Centre, NOVA University Lisbon, 1600-560, Lisbon, Portugal; Comprehensive Health Research Center (CHRC), NOVA University Lisbon, 1600-560, Lisbon, Portugal
| | | | - Marjolijn Woutersen
- National Institute for Public Health and the Environment, Bilthoven, the Netherlands
| | - Greet Schoeters
- VITO-Flemish Institute for Technological Research, Mol, Belgium; University of Antwerp, Dept of Biomedical Sciences, Antwerp, Belgium
| |
Collapse
|
4
|
Pena A, Duarte S, Pereira AMPT, Silva LJG, Laranjeiro CSM, Oliveira M, Lino C, Morais S. Human Biomonitoring of Selected Hazardous Compounds in Portugal: Part I-Lessons Learned on Polycyclic Aromatic Hydrocarbons, Metals, Metalloids, and Pesticides. Molecules 2021; 27:242. [PMID: 35011472 PMCID: PMC8746698 DOI: 10.3390/molecules27010242] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/19/2021] [Revised: 12/24/2021] [Accepted: 12/26/2021] [Indexed: 11/17/2022] Open
Abstract
Human biomonitoring (HBM) data provide information on total exposure regardless of the route and sources of exposure. HBM studies have been applied to quantify human exposure to contaminants and environmental/occupational pollutants by determining the parent compounds, their metabolites or even their reaction products in biological matrices. HBM studies performed among the Portuguese population are disperse and limited. To overcome this knowledge gap, this review gathers, for the first time, the published Portuguese HBM information concerning polycyclic aromatic hydrocarbons (PAHs), metals, metalloids, and pesticides concentrations detected in the urine, serum, milk, hair, and nails of different groups of the Portuguese population. This integrative insight of available HBM data allows the analysis of the main determinants and patterns of exposure of the Portuguese population to these selected hazardous compounds, as well as assessment of the potential health risks. Identification of the main difficulties and challenges of HBM through analysis of the enrolled studies was also an aim. Ultimately, this study aimed to support national and European policies promoting human health and summarizes the most important outcomes and lessons learned through the HBM studies carried out in Portugal.
Collapse
Affiliation(s)
- Angelina Pena
- LAQV, REQUIMTE, Laboratory of Bromatology and Pharmacognosy, Faculty of Pharmacy, University of Coimbra, Polo III, Azinhaga de Sta Comba, 3000-548 Coimbra, Portugal; (A.P.); (A.M.P.T.P.); (L.J.G.S.); (C.S.M.L.); (C.L.)
| | - Sofia Duarte
- LAQV, REQUIMTE, Laboratory of Bromatology and Pharmacognosy, Faculty of Pharmacy, University of Coimbra, Polo III, Azinhaga de Sta Comba, 3000-548 Coimbra, Portugal; (A.P.); (A.M.P.T.P.); (L.J.G.S.); (C.S.M.L.); (C.L.)
- Centro de Investigação Vasco da Gama-Departamento de Ciências Veterinárias, Escola Universitária Vasco da Gama, Av. José R. Sousa Fernandes, Campus Universitário-Bloco B, 3020-210 Coimbra, Portugal
| | - André M. P. T. Pereira
- LAQV, REQUIMTE, Laboratory of Bromatology and Pharmacognosy, Faculty of Pharmacy, University of Coimbra, Polo III, Azinhaga de Sta Comba, 3000-548 Coimbra, Portugal; (A.P.); (A.M.P.T.P.); (L.J.G.S.); (C.S.M.L.); (C.L.)
| | - Liliana J. G. Silva
- LAQV, REQUIMTE, Laboratory of Bromatology and Pharmacognosy, Faculty of Pharmacy, University of Coimbra, Polo III, Azinhaga de Sta Comba, 3000-548 Coimbra, Portugal; (A.P.); (A.M.P.T.P.); (L.J.G.S.); (C.S.M.L.); (C.L.)
| | - Célia S. M. Laranjeiro
- LAQV, REQUIMTE, Laboratory of Bromatology and Pharmacognosy, Faculty of Pharmacy, University of Coimbra, Polo III, Azinhaga de Sta Comba, 3000-548 Coimbra, Portugal; (A.P.); (A.M.P.T.P.); (L.J.G.S.); (C.S.M.L.); (C.L.)
| | - Marta Oliveira
- LAQV/REQUIMTE, Instituto Superior de Engenharia do Porto, Instituto Politécnico do Porto, Rua Dr. António Bernardino de Almeida 431, 4249-015 Porto, Portugal; (M.O.); (S.M.)
| | - Celeste Lino
- LAQV, REQUIMTE, Laboratory of Bromatology and Pharmacognosy, Faculty of Pharmacy, University of Coimbra, Polo III, Azinhaga de Sta Comba, 3000-548 Coimbra, Portugal; (A.P.); (A.M.P.T.P.); (L.J.G.S.); (C.S.M.L.); (C.L.)
| | - Simone Morais
- LAQV/REQUIMTE, Instituto Superior de Engenharia do Porto, Instituto Politécnico do Porto, Rua Dr. António Bernardino de Almeida 431, 4249-015 Porto, Portugal; (M.O.); (S.M.)
| |
Collapse
|
5
|
Human Biomonitoring of Selected Hazardous Compounds in Portugal: Part II—Lessons Learned on Mycotoxins. Molecules 2021; 27:molecules27010130. [PMID: 35011364 PMCID: PMC8747060 DOI: 10.3390/molecules27010130] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/19/2021] [Revised: 12/20/2021] [Accepted: 12/23/2021] [Indexed: 11/17/2022] Open
Abstract
Human biomonitoring (HBM) data provide information on total exposure regardless of the route and sources of exposure. HBM studies have been applied to quantify human exposure to contaminants and environmental/occupational pollutants by means of determining the parent compounds, their metabolites, or even their reaction products in biological matrices. HBM studies performed among the Portuguese population are dispersed and limited. Thus, to overcome this knowledge gap, this work reviews the published Portuguese HBM information concerning mycotoxins detected in the urine, serum, milk, hair, and nails of different groups of the Portuguese population. This integrative approach to the available HBM data allows us to analyze the main determinants and patterns of exposure of the Portuguese population to the selected hazardous compounds, as well as to assess the potential health risks. We also aimed to identify the main difficulties and challenges of HBM through the analysis of the enrolled studies. Ultimately, this study aims to support national and European policies in promoting human health by summarizing the most important outcomes and lessons learned through the HBM studies carried out in Portugal.
Collapse
|
6
|
Colles A, Coertjens D, Morrens B, Den Hond E, Paulussen M, Bruckers L, Govarts E, Covaci A, Koppen G, Croes K, Nelen V, Van Larebeke N, De Henauw S, Fierens T, Van Gestel G, Chovanova H, Mampaey M, Van Campenhout K, Loots I, Baeyens W, Schoeters G. Human Biomonitoring Data Enables Evidence-Informed Policy to Reduce Internal Exposure to Persistent Organic Compounds: A Case Study. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2021; 18:5559. [PMID: 34067438 PMCID: PMC8196998 DOI: 10.3390/ijerph18115559] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 04/02/2021] [Revised: 05/12/2021] [Accepted: 05/19/2021] [Indexed: 01/23/2023]
Abstract
Human biomonitoring (HBM) monitors levels of environmental pollutants in human samples, which often is a topic of concern for residents near industrially contaminated sites (ICSs). Around an ICS area in Menen (Belgium), including a (former) municipal waste incinerator and a metal recovery plant, increasing environmental concentrations of dioxins and polychlorinated biphenyls (PCBs) were observed, causing growing concern among residents and authorities. The local community succeeded in convincing the responsible authorities to investigate the problem and offer research funding. Persistent organic pollutants (POPs) were measured in two consecutive HBM studies (2002-2006 and 2010-2011), in the context of the Flemish Environment and Health Study (FLEHS), as well as in soil and locally produced food. Meanwhile, local authorities discouraged consumption of locally produced food in a delineated area of higher exposure risk. Ultimately, HBM and environmental data enabled tailored dietary recommendations. This article demonstrates the usefulness of HBM in documenting the body burdens of residents near the ICS, identifying exposure routes, evaluating remediating actions and providing information for tailored policy strategies aiding to further exposure reduction. It also highlights the role of the local stakeholders as an example of community-based participatory research and how such an approach can create societal support for research and policy.
Collapse
Affiliation(s)
- Ann Colles
- VITO Health, Boeretang 200, 2400 Mol, Belgium; (E.G.); (G.K.); (G.S.)
| | - Dries Coertjens
- Department of Sociology, Faculty of Social Sciences, University of Antwerp, Sint-Jacobstraat 2, 2000 Antwerp, Belgium; (D.C.); (B.M.); (I.L.)
| | - Bert Morrens
- Department of Sociology, Faculty of Social Sciences, University of Antwerp, Sint-Jacobstraat 2, 2000 Antwerp, Belgium; (D.C.); (B.M.); (I.L.)
| | - Elly Den Hond
- Provincial Institute of Hygiene, Kronenburgstraat 45, 2000 Antwerp, Belgium; (E.D.H.); (M.P.); (V.N.)
| | - Melissa Paulussen
- Provincial Institute of Hygiene, Kronenburgstraat 45, 2000 Antwerp, Belgium; (E.D.H.); (M.P.); (V.N.)
| | - Liesbeth Bruckers
- i-BioStat, Data Science Institute, Hasselt University, Martelarenlaan 42, 3500 Hasselt, Belgium;
| | - Eva Govarts
- VITO Health, Boeretang 200, 2400 Mol, Belgium; (E.G.); (G.K.); (G.S.)
| | - Adrian Covaci
- Toxicological Centre, University of Antwerp, Universiteitsplein 1, 2610 Antwerp, Belgium;
| | - Gudrun Koppen
- VITO Health, Boeretang 200, 2400 Mol, Belgium; (E.G.); (G.K.); (G.S.)
| | - Kim Croes
- Analytical, Environmental and Geo-Chemistry (AMGC), Vrije Universiteit Brussel, Pleinlaan 2, 1050 Brussels, Belgium; (K.C.); (N.V.L.); (W.B.)
| | - Vera Nelen
- Provincial Institute of Hygiene, Kronenburgstraat 45, 2000 Antwerp, Belgium; (E.D.H.); (M.P.); (V.N.)
| | - Nicolas Van Larebeke
- Analytical, Environmental and Geo-Chemistry (AMGC), Vrije Universiteit Brussel, Pleinlaan 2, 1050 Brussels, Belgium; (K.C.); (N.V.L.); (W.B.)
| | - Stefaan De Henauw
- Department of Public Health and Primary Care, Ghent University, C. Heymanslaan 10, 9000 Ghent, Belgium;
| | - Tine Fierens
- Flanders Environment Agency (VMM), Dr. De Moorstraat 24, 9300 Aalst, Belgium;
| | - Griet Van Gestel
- Public Waste Agency of Flanders (OVAM), Stationsstraat 110, 2800 Mechelen, Belgium;
| | - Hana Chovanova
- Flemish Ministry of Welfare, Public Health and Family, Flemish Agency for Care and Health, Environmental Health Section, Koning Albert-II laan 35 bus 33, 1030 Brussels, Belgium;
| | - Maja Mampaey
- Department of Environment & Spatial Development, Flemish Planning Bureau for the Environment and Spatial Development, Koning Albert-II laan 20 bus 8, 1000 Brussels, Belgium; (M.M.); (K.V.C.)
| | - Karen Van Campenhout
- Department of Environment & Spatial Development, Flemish Planning Bureau for the Environment and Spatial Development, Koning Albert-II laan 20 bus 8, 1000 Brussels, Belgium; (M.M.); (K.V.C.)
| | - Ilse Loots
- Department of Sociology, Faculty of Social Sciences, University of Antwerp, Sint-Jacobstraat 2, 2000 Antwerp, Belgium; (D.C.); (B.M.); (I.L.)
| | - Willy Baeyens
- Analytical, Environmental and Geo-Chemistry (AMGC), Vrije Universiteit Brussel, Pleinlaan 2, 1050 Brussels, Belgium; (K.C.); (N.V.L.); (W.B.)
| | - Greet Schoeters
- VITO Health, Boeretang 200, 2400 Mol, Belgium; (E.G.); (G.K.); (G.S.)
| |
Collapse
|
7
|
Participant Experiences in a Human Biomonitoring Study: Follow-Up Interviews with Participants of the Flemish Environment and Health Study. TOXICS 2021; 9:toxics9040069. [PMID: 33800558 PMCID: PMC8066005 DOI: 10.3390/toxics9040069] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 02/23/2021] [Revised: 03/19/2021] [Accepted: 03/22/2021] [Indexed: 11/17/2022]
Abstract
Communicating individual human biomonitoring results to study participants has been the subject of debate for some time. This debate is dominated by ethical considerations from a researchers’ perspective on whether or not to communicate, thereby overlooking more practice-based questions from a participants’ perspective on what and how to communicate. We conducted a small scale follow-up study based on eleven face-to-face interviews with mothers participating in the third cycle of the Flemish Environment and Health Study (FLEHS III 2012–2015) to investigate how they experienced and interpreted individual biomonitoring results. Key findings indicate that respondents were generally satisfied with participating in the biomonitoring study, but the report-back process especially lacked contextualized information and interactive communication options to better comprehend and cope with personal results. These findings also argue in favor of a more tailored approach in which report-back methods, formats and content are diversified according to the type of results and the preferences of participants. A reflexive research practice with active engagement in follow-up research is crucial to improve participants’ understanding and use of personal biomonitoring results.
Collapse
|
8
|
Fillol C, Oleko A, Saoudi A, Zeghnoun A, Balicco A, Gane J, Rambaud L, Leblanc A, Gaudreau É, Marchand P, Le Bizec B, Bouchart V, Le Gléau F, Durand G, Denys S. Exposure of the French population to bisphenols, phthalates, parabens, glycol ethers, brominated flame retardants, and perfluorinated compounds in 2014-2016: Results from the Esteban study. ENVIRONMENT INTERNATIONAL 2021; 147:106340. [PMID: 33422968 DOI: 10.1016/j.envint.2020.106340] [Citation(s) in RCA: 41] [Impact Index Per Article: 13.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/19/2020] [Revised: 12/10/2020] [Accepted: 12/12/2020] [Indexed: 06/12/2023]
Abstract
BACKGROUND As part of the French Human Biomonitoring (HBM) programme, the Esteban study described, among other things, biomarkers levels of various chemicals in adults (18-74 years old) and children (6-17 years old). This paper describes the design of the study and provides, for the first time, data on the biological exposure of the general French population to a wide range of contaminants posing a threat to human health which are currently found in domestic environments. METHODS Esteban is a cross-sectional study conducted on a nationwide sample of the French general population. Exposure biomarkers of six families of contaminants deemed detrimental to adults' and children's health were measured in biological samples collected either at participants' homes by a nurse, or brought to a National Health Insurance examination centre. All participants were randomly selected (2503 adults and 1104 children). The geometric mean and percentiles of the distribution of levels were estimated for each biomarker. Most of the descriptive statistical analyses were performed taking into account the sampling design. RESULTS Results provided a nationwide description of biomarker levels. Bisphenols (A, S and F), and some metabolites of phthalates and perfluorinated compounds (PFCs) (specifically, PFOS and PFOA) were quantified in almost all the biological samples analysed. Higher levels were observed in children (except for PFCs). Levels were coherent with international studies, except for bisphenols S and F, brominated flame retardants (BFRs) and parabens (with higher levels reported in the USA than in France). CONCLUSION AND PERSPECTIVES This study is the first to provide a representative assessment of biological exposure to domestic contaminants at the French population level. Our results show that the French general population was exposed to a wide variety of pollutants in 2014-2016, and identify the determinants of exposure. These findings will be useful to stakeholders who wish to advocate an overall reduction in the French population's exposure to harmful substances. Similar future studies in France will help to measure temporal trends, and enable public policies focused on the reduction of those chemicals in the environment to be evaluated.
Collapse
Affiliation(s)
- Clémence Fillol
- Santé publique France, 12 rue du Val d'Osne, 94415 Saint Maurice Cedex, France.
| | - Amivi Oleko
- Santé publique France, 12 rue du Val d'Osne, 94415 Saint Maurice Cedex, France
| | - Abdesattar Saoudi
- Santé publique France, 12 rue du Val d'Osne, 94415 Saint Maurice Cedex, France
| | - Abdelkrim Zeghnoun
- Santé publique France, 12 rue du Val d'Osne, 94415 Saint Maurice Cedex, France
| | - Alexis Balicco
- Santé publique France, 12 rue du Val d'Osne, 94415 Saint Maurice Cedex, France
| | - Jessica Gane
- Santé publique France, 12 rue du Val d'Osne, 94415 Saint Maurice Cedex, France
| | - Loïc Rambaud
- Santé publique France, 12 rue du Val d'Osne, 94415 Saint Maurice Cedex, France
| | - Alain Leblanc
- Centre de Toxicologie du Québec (CTQ), Institut National de Santé Publique du Québec (INSPQ), Canada
| | - Éric Gaudreau
- Centre de Toxicologie du Québec (CTQ), Institut National de Santé Publique du Québec (INSPQ), Canada
| | - Philippe Marchand
- Oniris, INRAE, LABERCA Route de Gachet, Site de la Chantrerie, CS 50707, 44307 Nantes Cedex 3, France
| | - Bruno Le Bizec
- Oniris, INRAE, LABERCA Route de Gachet, Site de la Chantrerie, CS 50707, 44307 Nantes Cedex 3, France
| | - Valérie Bouchart
- LABEO, 1 Route de Rosel, Saint Contest, 14053 Caen Cedex 4, France
| | | | - Gaël Durand
- LABOCEA, 120 avenue de Rochon, CS10052, 29280 Plouzané, France
| | - Sébastien Denys
- Santé publique France, 12 rue du Val d'Osne, 94415 Saint Maurice Cedex, France
| |
Collapse
|
9
|
A Phased Approach for preparation and organization of human biomonitoring studies. Int J Hyg Environ Health 2020; 232:113684. [PMID: 33373963 DOI: 10.1016/j.ijheh.2020.113684] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/18/2020] [Accepted: 12/13/2020] [Indexed: 11/20/2022]
Abstract
BACKGROUND Human biomonitoring (HBM) studies like other epidemiological studies are costly and time-consuming. They require the administration of questionnaires and collection of biological samples, putting substantial burden on the participants which may result in low participation rates. The growing importance of HBM studies in epidemiology, exposure assessment and risk assessment underline the importance of optimizing study planning, designing and implementation thus minimizing the above-mentioned difficulties. METHODS Based on frameworks from survey design and fieldwork preparation of the European Joint Program HBM4EU, the German Environment Surveys and the COPHES/DEMOCOPHES twin projects combined with elements of project management strategies, a Phased Approach has been developed, introducing a step-by-step guideline for the development of epidemiological studies. RESULTS The Phased Approach splits the process of developing a study into six phases: Phase 0 (Scoping and Planning): All aspects that are necessary to conduct a study are compiled and put on the agenda for decision-making. Phase 1 (Preparation and Testing): Instruments (e.g. questionnaires), materials (e.g. guidelines, information), and ethics and data management issues, needing thorough preparation and testing before a study can start. Phase 2 (Initiation): Organization and acquisition of necessary equipment and engaging and training personnel. Phase 3 (Implementation): All procedures that require temporal proximity to the start date of fieldwork, such as obtaining contact information of invitees. Phase 4 (Fieldwork and Analysis): Involvement of participants and chemical analysis of the collected samples. Phase 5 (Results and Evaluation): Final procedures leading to closure of the project, such as providing and communicating results. CONCLUSIONS The separation of the planning and conduct of human biomonitoring studies into different phases creates the basis for a structured procedure and facilitates a step-by-step approach reducing costs, warranting high participation rates and increasing quality of conduct. Emphasis is put on a comprehensive scoping phase ensuring high quality of the study design, which is indispensable for reliable results.
Collapse
|
10
|
Fuchs Weizman N, Baram S, Montbriand J, Librach CL. Planned oocyte cryopreservation (Planned OC): systematic review and meta-analysis of cost-efficiency and patients' perspective. BJOG 2020; 128:950-962. [PMID: 33021076 DOI: 10.1111/1471-0528.16555] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 09/28/2020] [Indexed: 11/27/2022]
Abstract
BACKGROUND Advances in vitrification techniques have enabled planned oocyte cryopreservation ('Planned OC'). OBJECTIVES To explore the cost-efficiency and utilisation of planned OC, as well as patients' perspectives on the process. SEARCH STRATEGY A systematic search in PubMed/MEDLINE, Embase, Cochrane Database and PsychINFO, for all relevant studies published between January 2007 and December 2019. SELECTION CRITERIA The protocol followed PRISMA guidelines in PECO format, and was registered with PROSPERO. DATA COLLECTION AND ANALYSIS Two independent reviewers evaluated all manuscripts for inclusion eligibility. Authors were contacted for missing data. Included studies were assessed for risk of bias and for heterogeneity. Weighted effects were measured and plotted. MAIN RESULTS The search yielded 12 545 records, of which 43 were included. Planned OC is cost-efficient at 35, assuming 60% utilisation; and at 37 assuming utilising donor sperm when necessary. At 38 it is cost-efficient to defer planned OC in favour of undergoing 2 IVF cycles. Currently, utilisation of banked-oocytes within 22-58 months, is up to 15%. Nine percent of warmed banked oocytes result in life births. Online resources and treating physicians are equally important sources of information regarding planned OC. Most patients think planned OC is ideal before age 35 and are not fully aware of what the process entails and tend to overestimate the success rates. The main barrier to wider endorsement of planned OC is being wary of potential health implications or of limited success. CONCLUSION Planned OC is an adequate method for preserving fertility. However, knowledge gaps result in under-utilisation leading to reduced cost-efficiency. TWEETABLE ABSTRACT Identifying facilitators and barriers for wider adoption of banking oocytes can enhance the cost-efficiency of this modality.
Collapse
Affiliation(s)
| | - S Baram
- CReATe Fertility Centre, Toronto, ON, Canada
| | - J Montbriand
- Department of Anaesthesia, Sunnybrook Health Sciences Centre, Toronto, ON, Canada
| | - C L Librach
- CReATe Fertility Centre, Toronto, ON, Canada.,Faculty of Medicine, Department of Obstetrics and Gynaecology, University of Toronto, Toronto, ON, Canada
| |
Collapse
|
11
|
Pirard C, Dufour P, Charlier C. Background contamination of perfluoralkyl substances in a Belgian general population. Toxicol Lett 2020; 333:13-21. [PMID: 32659468 DOI: 10.1016/j.toxlet.2020.07.015] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/29/2019] [Revised: 07/02/2020] [Accepted: 07/09/2020] [Indexed: 10/23/2022]
Abstract
The few Belgian studies on the human exposure to perfluoroalkyl substances (PFASs) have until now concerned the Northern part of Belgium (Flanders), while data related to Wallonia (South region) are missing. To fill this gap, 8 perfluorinated carboxylic acids and 3 perfluorinated alkyl sulfonates were measured in the serum of 242 adults (>18 years old) recruited in 2015 and living in the Province of Liege. Some multivariate regression models were also built with the PFAS levels and the participant's answers to a questionnaire about their diet and lifestyle habits in order to identify some predictors of exposure. The results obtained showed that although PFAS levels observed in our population seemed to be similar or lower than those reported in other countries, and especially lower than in the Northern part of Belgium, half of the population showed PFOS and PFOA serum levels above the health guidance values set by the German HBM Commission. As expected, age and gender were the main covariates explaining the different PFAS serum levels between participants, while breastfeeding (for women), consumption of fish and seafood, consumption of rice, and use of nail polish seemed also to impact the PFAS body burden of our population. Nevertheless, the statistical models were poorly predictive suggesting that the main sources of exposure were not taken into account.
Collapse
Affiliation(s)
- Catherine Pirard
- Laboratory of Clinical, Forensic and Environmental Toxicology, CHU of Liege, B35, 4000, Liege, Belgium.
| | - Patrice Dufour
- Laboratory of Clinical, Forensic and Environmental Toxicology, CHU of Liege, B35, 4000, Liege, Belgium
| | - Corinne Charlier
- Laboratory of Clinical, Forensic and Environmental Toxicology, CHU of Liege, B35, 4000, Liege, Belgium
| |
Collapse
|
12
|
Van Den Heuvel R, Den Hond E, Colles A, Nelen V, Van Campenhout K, Schoeters G. Biobank@VITO: Biobanking the General Population in Flanders. Front Med (Lausanne) 2020; 7:37. [PMID: 32118021 PMCID: PMC7033607 DOI: 10.3389/fmed.2020.00037] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2019] [Accepted: 01/27/2020] [Indexed: 11/13/2022] Open
Abstract
During the last 15 years, VITO has established an infrastructure for biobanking a collection of biological samples from the general population in Flanders (Belgium). This biobank was set up to contribute to future, yet unspecified, research questions in the field of environment and health. Biobank@VITO is a population biobank in which bio-specimen including human peripheral blood, cord blood, and blood derivatives (e.g., serum, plasma, cells, RNA, DNA), urine, hair, nails, exhaled breath condensate, saliva DNA, and human breast milk collected from non-diseased populations are preserved. Currently, the biobank stores about 70,000 samples from 7,700 individuals. These biospecimen were collected since 2002 in different human biomonitoring studies comprising European (e.g., DEMOCOPHES, HBM4EU), national (e.g., WHO human breastmilk studies), Flemish (Flemish Environment and Health Study (FLEHS) campaigns), and local (e.g., hotspots, 3xG project) well-defined and ethically approved research projects. Participants to the surveys included different age groups (newborns, children, adolescents, and adults) and were representatively selected with regard to gender, age class, residence, and/or socioeconomic status (SES). In each campaign, samples were stored in the Biobank@VITO. The registration, preservation, and management of the samples in the biobank were done in a qualitative and uniform manner which guarantees the traceability of all samples. The samples in the biobank have an extended information backbone on the lifestyle, environment, and health status of the donor. The biological samples in the biobank are an invaluable archive that can be used to address specific policy and research questions in the future, to test old samples with new technology and according to the latest methods and insights or to measure newly identified pollutants in old samples looking for long-term trends.
Collapse
Affiliation(s)
- Rosette Van Den Heuvel
- Unit Health, Flanders' Research and Technology Organisation on Cleantech and Sustainable Development (VITO), Mol, Belgium
| | - Elly Den Hond
- Department of Environment, Provincial Institute for Hygiene (PIH), Antwerp, Belgium
| | - Ann Colles
- Unit Health, Flanders' Research and Technology Organisation on Cleantech and Sustainable Development (VITO), Mol, Belgium
| | - Vera Nelen
- Department of Environment, Provincial Institute for Hygiene (PIH), Antwerp, Belgium
| | | | - Greet Schoeters
- Unit Health, Flanders' Research and Technology Organisation on Cleantech and Sustainable Development (VITO), Mol, Belgium
| |
Collapse
|
13
|
Gerić M, Gajski G, Oreščanin V, Garaj-Vrhovac V. Seasonal variations as predictive factors of the comet assay parameters: a retrospective study. Mutagenesis 2017; 33:53-60. [DOI: 10.1093/mutage/gex023] [Citation(s) in RCA: 22] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/21/2017] [Accepted: 08/24/2017] [Indexed: 11/13/2022] Open
Affiliation(s)
- Marko Gerić
- Mutagenesis Unit, Institute for Medical Research and Occupational Health, Zagreb, Croatia
| | - Goran Gajski
- Mutagenesis Unit, Institute for Medical Research and Occupational Health, Zagreb, Croatia
| | | | - Vera Garaj-Vrhovac
- Mutagenesis Unit, Institute for Medical Research and Occupational Health, Zagreb, Croatia
| |
Collapse
|